PepGen PEPG
NASDAQ PEPG
$5.26 +0.65 (+14.10%)
At close: Nov 11, 2026 · 4:00 PM EST

PepGen (PEPG) Total Non-Current Liabilities (2021 - 2022)

Updated

PepGen (PEPG) recorded Total Non-Current Liabilities of $181.3 million in Q1 2022, up 3.3% from the prior quarter.

Analysis

PepGen (PEPG) Total Non-Current Liabilities (2021 - 2022) Analysis & Trends

At the end of FY2021, PepGen reported Total Non-Current Liabilities of $175.5 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 PepGen 319.29 Mn -183.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 181.30 Mn
Dec 31, 2021 175.50 Mn
API Access

PepGen Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PEPG&period=max&api_key=YOUR_API_KEY